RYTM PRESS-RELEASE SEC Filing Analysis

Latest settled — T+5d

RYTM ▼ -2.17% at T+5d

NEUTRAL call ✗ call lost -2.17% · α vs SPY -3.25% · entry $89.82 → $87.87

Next anchor: T+20d in 11d

Currently $88.38 · -1.60% from $89.82 entry

Entry anchored
May 26, 05:51 AM ET
via Databento tick

T+1d

+1.78%

call +1.78% · α +1.77%

$91.42

settled 17d ago

T+5d

-2.17%

call -2.17% · α -3.25%

$87.87

settled 11d ago

T+20d

—

call — · α —

—

in 11d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Rhythm Pharmaceuticals announced that its CEO and CFO will participate in fireside chats at the Jefferies Global Healthcare Conference (June 4) and Goldman Sachs 47th Annual Global Healthcare Conference (June 8). This is a routine investor relations event with no new financial data, clinical updates, or regulatory decisions disclosed.

Actionable Insight

Monitor the webcasts for any strategic commentary on setmelanotide label expansion or pipeline progress, but this filing alone does not warrant a trading action. The stock's historical T+20 alpha is negative (-8.07% vs SPY), suggesting limited near-term catalysts from routine IR events.

Key Facts

CFO Hunter Smith to speak at Jefferies Global Healthcare Conference on June 4, 2026 at 12:50 p.m. ET
CEO David Meeker to speak at Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026 at 1:20 p.m. ET
Webcasts will be available on the company's investor relations page with replays for 30 days
No financial results, guidance, clinical data, or regulatory updates were provided in this release

Financial Impact

No financial impact — this is a routine conference participation announcement with no material financial data disclosed.

Risk Factors

No new clinical or financial data — stock may be range-bound until next catalyst
Historical calibration shows low observed probability of positive T+20 moves for score-6/7 filings on this ticker (29% each)

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

91% bullish (22 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3300998

9 reports for RYTM

T+1T+5T+20T+60

50% Hit rate 2 of 4 directional calls best @ T+5▲ +15.11%May 1, 2026

Filters

Reports for RYTM — sortable, filterable
	Type				Now
Jun 13, 2026 today	Press Release BULLISH ★ 7/10	—	awaiting T+5	—	—
May 26, 2026 18d ago	Press Release NEUTRAL ★ 2/10	$89.82 $87.87	▼ −2.17%	▼ −3.25%	$88.38 (−1.60%)
May 12, 2026 4w ago	Press Release NEUTRAL ★ 4/10	$91.31 $86.84	▼ −4.90%	▼ −4.97%	$88.38 (−3.21%)
May 5, 2026 5w ago	8-K MIXED ★ 6/10	$92.31 $91.31	▼ −1.08%	▼ −3.07%	$88.38 (−4.26%)
May 5, 2026 5w ago	Press Release BULLISH ★ 7/10	$92.31 $91.31	▼ −1.08%	▼ −3.07%	$88.38 (−4.26%)
May 1, 2026 6w ago	Press Release BULLISH ★ 7/10	$81.81 $94.17	▲ +15.11%	▲ +12.76%	$88.38 (+8.03%)
Apr 3, 2026 10w ago	8-K NEUTRAL ★ 3/10	$86.96 $86.81	▼ −0.17%	▼ −4.31%	$88.38 (+1.63%)
Mar 1, 2026 14w ago	Press Release BULLISH ★ 8/10	$94.94 $93.00	▼ −2.04%	▼ −0.84%	$88.38 (−6.91%)
Feb 26, 2026 15w ago	8-K BULLISH ★ 8/10	$98.07 $91.46	▼ −6.74%	▼ −5.61%	$88.38 (−9.88%)

US Market Status

Market Closed — Opens Mon (48h 37m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access